Susan Hasty, Publisher
Table of Contents . . . July 29th, 1996Non-Subscriber - Summaries Only
Conference Coverage (Vancouver) - Canarypox HIV Vaccine: Time for Large-Scale Trials?
Conference Coverage (Vancouver) - Existing HIV Vaccines Induce Neutralizing Antibodies to Primary Isolates
Conference Coverage (Vancouver) - Genentech Researchers: Subunit Vaccine May Be Protective
AIDS Therapies (Remune) - Immune-Based Therapy Trial Participation for HIV Announced
Cervical Cancer - Experts Confirmed HPV A Major Cause of Cancer
DNA Vaccines (Hepatitis B) - DNA Vaccine for HBV Tested and Compared in Chimpanzee Model
HIV Vaccines - Clinical Details of Study with HGP-30 Vaccine Presented
Measles - Immunology: One Less Mystery
Pediatrics (DTP Vaccines) - Infanrix Recommended for DTaP Vaccination Series
Pneumococcal Pneumonia - Partnership Formed To Vaccinate High-Risk Groups
Vaccines (Antiviral) - B7-1 Enhances CTL and Antibody Response to Hepatitis B Surface Antigen
Vector Development - Reverse Genetics Generates a Chimeric Nonsegmented Negative Strand Vector
Vector Development (Synthetic) - Stable Cationic Lipid/DNA Complexes Developed for Gene Transfer
DNA Vaccine (HIV) - "Induction of HIV-1 Nef Specific CTLs by Nef Expressing DNA Vaccine."
Prophylaxis (HBV Vaccine) - "Response to Hepatitis B Virus Vaccination Among a Cohort of HIV+ Youth."
Vaccine Development (HIV) - "Highly Divergent env Sequence of HIV-1 B Subtype and Dual Infection of HIV-1 B and E Subtypes."